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Oncogene-induced senescence (OIS) is a potent
barrier for the transformation of pre-cancerous cells.
The molecular pathways involved in the execution of
OIS are still incompletely understood, but they
include chronic DNA damage signaling and post-
translational modifications of key factors. Here, we
show that OIS-associated transcriptional downregu-
lation of deubiquitinating enzyme USP1 triggers and
maintains a DNA damage checkpoint response with
atypical DNA lesions that is dependent on functional
FANCD2-FI-ATR-CHK1-p53-CDKN1A signaling. We
find that a reduced USP1 level causes aberrant
aggregation of its target FANCD2 concomitant
with replication stress, accumulation, and colocali-
zation of g-H2Ax and p53-binding protein 1 (53BP1)
in large and unusual sparse DNA damage foci and
an increased number of polyploid cells and cells
arrested in G2/M, as well as a sensitization of senes-
cence-bypassing cells to DNA interstrand crosslink-
ing-mediated cell death. Our study identifies USP1
as a key senescence regulator controlling genomic
integrity and a promising target for anti-cancer
therapy.INTRODUCTION
Cellular senescence is a tumor suppressor mechanism that sta-
bly arrests cell proliferation of pre-cancerous cells. The arrest is
accompanied by a senescence-associated secretory phenotype
(SASP), the expression of many inflammatory cytokines and
growth factors, that reinforces the senescence arrest. TheCe
This is an open access article under the CC BY-Nmost prominent senescence-inducing stimuli are activated
oncogenes (e.g., oncogenic RAS and oncogene-induced senes-
cence [OIS]). Irrespective of the stimulus, two major tumor sup-
pressor pathways are activated: p53/CDKN1A (alias p21CIP) and
Rb/CDKN2A (alias p16) (Campisi, 2013). OIS is triggered, at least
in part, by DNA replication stress and a concomitant activation of
a persistent DNA damage response (DDR), resulting in SASP
activation and G1, intra-S, and G2/M cell-cycle checkpoint
arrests. OIS also is characterized by an increase in g-H2Ax
and phospho-53BP1 DNA damage foci and mediated by
ATM:CHK2/ATR:CHK1 kinases as well as p53 and its down-
stream target CDKN1A (Bartek et al., 2007; d’Adda di Fagagna,
2008). OIS-associated replication stress is affiliated with an
increased replication origin firing and reduced replication fork
progression (Hills and Diffley, 2014). However, our knowledge
concerning the factors and underlying mechanisms involved in
this process is still incomplete.
Ubiquitin conjugation is dynamically controlled by deubiquiti-
nating enzymes (DUBs) and regulates many cellular functions
including replication (Chen and Sun, 2009; Reyes-Turcu et al.,
2009). For example, DUB USP1 regulates the function of inhibi-
tors of DNA binding (IDs1–4), proliferating cell nuclear antigen
(PCNA), as well as Fanconia Anemia (FA) pathway proteins
FANCD2 (FD2) and FANCI (FI) by counteracting their mono-ubiq-
uitination (Nijman et al., 2005; Williams et al., 2011; Huang et al.,
2006). IDs are HLH transcription factors that inhibit differentiation
and senescence (Zebedee and Hara, 2001). USP1 promotes ID
protein stability and antagonizes differentiation and also en-
hances stem cell maintenance by regulating CKN1A expression
(Williams et al., 2011). USP1-mediated deubiquitination of the
DNA replication processivity factor, PCNA, acts as a safeguard
against error-prone translesion synthesis (TLS) of DNA (Huang
et al., 2006). Mono-ubiquitination of FD2 (FD2-Ub) and FI
(FI-Ub) is a key event in the activation of the FA pathway that con-
tributes to the resolution of endogenous replication-coupled
DNA inter-strand crosslinks (ICLs). In line with this, FD2-Ubll Reports 15, 1401–1411, May 17, 2016 ª 2016 The Authors 1401
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
and FI-Ub interact with and recruit DNA repair proteins at DNA
damage foci for DNA repair (Jones and Huang, 2012). Moreover,
FD2-Ub was shown to be necessary for coordinating the firing of
replication origins in unperturbed conditions (Panneerselvam
et al., 2014), while unmodified FD2 is involved in replisome sur-
veillance (Lossaint et al., 2013). Thus, the interaction among
FD2, FI, and the replication machinery is complex and involves
both the modified and unmodified forms of FD2 and possibly FI.
FD2 and FD2-Ub also are critical for senescence. In USP1-
knockout (KO) mouse embryonic fibroblasts (MEFs), FD2-Ub
accumulates and was shown to activate pro-senescence factor
TAp63 expression, a homolog of tumor suppressor p53. How-
ever, it is an open question whether this also occurs in human
cells and if other components of the FA pathway are involved.
In human cells, FD2 depletion induces a senescence-like arrest,
and replisome surveillance dysfunction was proposed as an un-
derlying mechanism (Lossaint et al., 2013; Park et al., 2013).
In this study, we sought to investigate the role of DUB USP1
and its substrates in cells undergoing OIS in human cells. Our
findings highlight the importance of USP1 and mono-ubiquitina-
tion of FD2 in the maintenance of proliferative homeostasis and
genome integrity by mitigating replication stress in human cells,
and they also reveal cell-type-, cell-context-, and species-
dependent differences of USP1 function.
RESULTS
USP1 Downregulation Is a Hallmark of OIS
To identify DUBs potentially involved in OIS, we analyzed our
Affymetrix and RNA sequencing (RNA-seq) gene expression
profiles (Martin et al., 2012; Neyret-Kahn et al., 2013). We found
that, of the 24 DUBs that were differentially regulated in senes-
cent cells when compared to pre-senescent cells, six were
upregulated (USP3, -12, -18, -36, -41, and -53) and 18 were
downregulated (USP1, -2, -9X, -9Y, -13, -24, -28, -30, -33, -34,
-37, -44, -46, -47, -48, -9, -50, and -51) at least 1.5-fold (p <
0.01) (Figure 1A; Table S1). Given the potential role of USP1 in
oncogenesis via FD2 (Moldovan and D’Andrea, 2009), we
focused further analysis on the function of this DUB in senes-
cence. We confirmed that oncogenic RAS senescent cells
have reduced USP1 transcript and protein levels compared to
pre-senescent cells (Figure 1B, upper and lower panels). Using
a tamoxifen-inducible retroviral ER:RAS expression system, we
determined that downregulation of USP1 expression already
begins at day 2 post-induction, thus, preceding CDKN1A upre-
gulation and at a time when cells are in transit between the hy-
per-proliferative to full senescence phase (Martin et al., 2012)
(Figure S1A). Stable silencing of USP1 expression in two different
NHF strains (WI38 and BJ), using three individual knockdown
constructs (shUSP1-1, shUSP1-2, and shUSP1-3), induced a
cell-cycle arrest with senescence features, including a perma-
nent proliferative arrest (Figure 1C), a flat cell morphology, and
increased senescence-associated beta-galactosidase (SABG)
positivity (Figure 1D) with a concomitant decrease in Ki67
expression (Figure 1E). Similar results were obtained upon
depleting USP1-associated factor 1 (UAF1), an essential USP1
cofactor, showing that deubiquitination activity of USP1 per se
is necessary for cell proliferation (Figures S1B–S1E).1402 Cell Reports 15, 1401–1411, May 17, 2016UAF1 also interacts with DUBs USP12 and USP46 (Garcı´a-
Santisteban et al., 2013) and, thus, both genes also could be
involved in senescence. Toexclude thispossibility and todemon-
strate specificity for USP1-dependent senescence, we silenced
their expression and that of USP53 (Table S1) as an additional
specificity control. Transient depletion of USP12, USP46, and
USP53 did not induce a senescence arrest (Figures S1F–S1I).
If USP1 downregulation actively contributes to the OIS pheno-
type, then overexpressing either wild-type (WT) or a catalytically
inactive mutant USP1 (USP1mt) (Figure S1J) should delay OIS
onset. Indeed, we found that overexpression of USP1WTprotein
partially delayed onset of OIS asmeasured by a 3.3-fold increase
in EdU incorporation compared to control cells (Figure 1F). Inter-
estingly, we also found a 2.4-fold increase in EdU incorporation
of cells ectopically expressing USP1mt protein, suggesting that
USP1 may exert both enzymatic and non-enzymatic effects in
this scenario.
Together, these results provide strong evidence that USP1
repression is not only associated with the senescence response
but also may actively contribute to it.
USP1 Depletion Triggers a G2/M Checkpoint Arrest
Dependent on p53 and CDKN1A
Cell-cycle profiling showed that USP1-depleted cells had a
1.8-fold diminished S phase (3.9% versus 7.1%) and 1.3-fold
diminished G1 phase (56.7% versus 72%) content, but a 1.8-
fold increased G2/M phase (32.4% versus 18.3%) and 2.5-fold
increased polyploid (6.7% versus 2.6%) population compared
to controls, thus pointing toward a prominent G2/M checkpoint
arrest in these cells (Figure 2A). The increased ploidy of USP1-
depleted cells also was evident at the single-cell level by an
increase in bi- and multi-nucleated cells (20% versus 1%)
(Figure 2B).
Previous studies demonstrated the importance of p53/
CDKN1A and Rb/CDKN2A pathways in senescence. We re-
producibly found (Figure 2C) that USP1 depletion caused p53
phosphorylation on serine 15 (Ser15), a key phosphorylation
site during DDR-induced p53 activation (row 2). Consistent
with this, both expression of its transcriptional target gene
CDKN1A (alias p21 or WAF1/CIP1) (row 3) and levels of hypo-
phosphorylated, active forms of Rb were increased (row 4). We
then determined gene expression levels of SASP factors IL1a
and IL6 that are readouts for a chronic DDR in senescence (Rod-
ier et al., 2009). We detected a3- to 4-fold upregulation of both
cytokines in USP1-silenced cells (Figure 2D).
To establish the role of p53/CDKN1A and Rb/CDKN2A
pathways, we depleted USP1 in cells stably expressing either
oncoviral protein HPV16E6 (which perturbs p53 function by
degradation) or HPV16E7 (which perturbs Rb function by desta-
bilization) and in cells somatically knocked out for CDKN1A
(CDKN1AKO) (Brown et al., 1997). Cells constitutively expressing
shUSP1 alone or together with HPV16E7 (Figure 2E) or
CDKN1AWT (Figure 2G) rapidly entered senescence. In contrast,
HPV16E6/shUSP1- (Figure 2F) and CDKN1AKO/shUSP1- (Fig-
ure 2G) expressing cells proliferated normally (Figures 2E and
2F) and stained strongly positive for Ki67 but mostly negative
for SABG when compared to control cells (Figure 2H). Cell-cycle
analysis of CDKN1AKO/shC and CDKN1AKO/shUSP1 indicated a
Figure 1. USP1 Repression Actively Contributes to OIS
(A) Heatmap of USP1 expression based on Affymetrix transcriptome analysis in pre-senescent (PS) and oncogenic RAS-expressing primary fibroblast strain
WI38. Expression analysis was performed in triplicate and mean (Ø) of the three is shown on the right side of the heatmap (p < 0.05).
(B) Relative quantification of USP1 expression by qRT-PCR (upper panel) and western blot analysis (lower panel) compares primary fibroblast strain BJ
undergoing RAS-induced senescence to PS fibroblasts .
(C) Proliferation curves of BJ and WI38 primary fibroblasts infected with pRETROSUPER-shScramble (shC1 and -2), pRETROSUPER-shUSP1-1, shUSP1-2, or
shUSP1-3. Number of population doublings (PDs) was determined over the indicated period of time. PDs for each time point are the mean value of triplicates ±
SEM. Also shown is the expression of USP1 using qRT-PCR (lower bar diagram).
(D and E) Percentage of infected BJ fibroblasts staining positive for (D) SABG (scale bar, 100 mm) and for (E) proliferation marker Ki67 at day 10 post-selection.
Plotted values are means ± SEM of three independent counts of >200 cells.
(F) Tamoxifen-inducible ER:RASV12 fibroblasts were transfected transiently with pcDNA3.1 (Control) or pcDNA-GFP-USP1 WT or pcDNA-GFP-USP1(C90S)mt
construct. Then 24–48 hr after transfection cells were induced into senescence by the addition of 400 nM 4-OHT (tamoxifen), and EdU incorporation was
measured at day 6 when pcDNA-expressing control cells were fully senescent.
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Figure 2. USP1 Silencing Induces p53-CDKN1A-Dependent G2/M Senescence Arrest
(A) Propidium iodide-stained control vector (shC) and shUSP1 BJ fibroblasts were analyzed by FACScan to determine cell-cycle distribution.
(B) Percentage of mono-, bi-, and multi-nuclear cells in scramble control vector (shC) and shUSP1 cells. Plotted values are means ± SEM of three independent
counts of >200 cells. Inset shows representative images of multi-nuclear senescent shUSP1 cells (indicated by arrows and stained for SABG positivity) and
respective shC control cells.
(C) Senescence-associated cell-cycle regulators p53-Ser15, p21, and hypo-phosphorylated Rb accumulate in USP1-depleted senescent cells.
(legend continued on next page)
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1.5-fold increase of CDKN1AKO/shUSP1-expressing cells in G2/
M phase (14.6% versus 22.4%) and a 2.2-fold increase in poly-
ploid cells (9.8% versus 22.4%) (Figure S2A).
Next we tested the potential role of USP1 substrates ID pro-
teins in the process. ID proteins are stabilized by USP1 and
are negative regulators of CDKN1A expression and senescence
(Williams et al., 2011; Zebedee and Hara, 2001). Consequently,
ID protein overexpression might rescue USP1-mediated senes-
cence by suppressing CDKN1A expression. Despite ectopic
expression of ID1 or -2, USP1-depleted cells (shUSP1/ID1 and
shUSP1/ID2) underwent senescence with the same kinetics as
control cells depleted for USP1 alone (shC/pBABE [B0] and
shC/pLXSN [LX]), thus precluding a major function of ID proteins
in USP1-mediated senescence (Figures S2B–S2D).
Together, these results show p53 and its major transcriptional
target CDKN1A to be key factors required for the senescence
arrest induced by USP1 depletion. Moreover, our data indicate
that it evokes a G2/M checkpoint arrest and a persistent DDR,
as evidenced by the upregulation of SASP factors IL1a and IL6.
USP1 Depletion Triggers ATR/RAD17/CHK1 DDR
Activation and Replication Stress
Dysfunctional telomeres cause a chronic DDR and senescence
(d’Adda di Fagagna et al., 2003; Herbig et al., 2004). We there-
fore performed USP1 depletion in hTERT-immortalized cells
known to stabilize telomeres. hTERT/shUSP1-overexpressing
cells entered senescence as efficient as cells expressing
shUSP1 alone (Figure S3A). We next tested whether ATM/
CHK2 and/or ATR/CHK1 pathways mediate USP1-dependent
senescence arrest. Co-silencing USP1 together with ATM,
CHK2, or ATR expression showed that cells co-expressing
shATM or shCHK2 together with shUSP1 RNA molecules (Fig-
ure S3B) entered senescence as cells expressing shUSP1 alone
(Figure 3A; Figures S3C–S3E). By contrast, simultaneous ATR
and USP1 silencing (Figure S3E) caused a marked delay in the
onset of senescence when compared to USP1-depleted control
cells, as evidenced by an1.7-fold increase in total cell numbers
(Figure 3B) and an 5-fold increase in the number of cells incor-
porating the BrdU derivative ethyl-deoxyuridine (EdU) at a time
(day 3) when USP1 silenced cells were already fully senescence
arrested (Figure 3C). Consistent with the above results, we found
that ATR downstream targets CHK1 and RAD17 were strongly
phosphorylated on Ser residues 345 and 645, respectively (Fig-
ure 3D), suggesting that USP1 depletion induces ATR-activating
DNA lesions. Employing both neutral and alkaline comet assays,
we found, however, no evidence for overt DNA lesions (Figure 3E;
Figure S3F).
We then analyzed the focal accumulation of markers of acti-
vated DDR by immunofluorescence at the single-cell level.
Here, we observed an 7-fold increase in the number of cells
staining positive for unusual large, sparse 53BP1- and gH2AX-
containing DNA damage foci in USP1-depleted cells compared(D) Expression levels of SASP factors IL1a and IL6 were detected by qRT-PCR in
establishment. Ribosomal protein P0 (RPP0) was used for normalization.
(E–G) Proliferation curves of BJ fibroblasts expressing (E) LXSN-16E7/shUSP1, L
and (G) LF1-CDKN1AWT or -CDKN1AKO fibroblasts expressing shUSP1. PDs for
(H) Percentages of indicated cell populations staining positive for proliferation mto control cells (Figures 3F and 3G). Together, these data sug-
gested that USP1 silencing may cause replication stress, the
prime inducer for an ATR-dependent G2/M checkpoint arrest
(Magiera et al., 2014). Accordingly, we analyzed the pattern of
whole-genome DNA replication in vivo by molecular DNA comb-
ing in fibroblasts (Figure S4A) expressing lentiviral shUSP1 alone
or in senescence-bypassing HPV16E6/shUSP1 and CDKN1AKO/
shUSP1 cells (see Figures 2F and 2G). USP1 knockdown alone
led to a strong and significant2-fold decrease in mean replica-
tion fork velocity (Figure 3H; Figure S4B), while in E6-expressing
and CDKN1AKO cells it caused a more moderate, but still highly
significant, 1.3-fold decrease in mean replication fork speed
when compared to control cells (Figures S4C and S4D). To
further investigate the role of USP1 in replisome dynamics, we
counted the number of replicated tracks per megabase of repli-
cating DNA in these cells (Figure 3I; Figure S4E). Here we
obtained a moderate, but highly significant, 1.5-fold increase
in the number of replication events per megabase, indicative of
an activation of dormant origins reflecting replication stress (Ka-
wabata et al., 2011).
Taken together, the data demonstrate that senescence
induced by USP1 depletion is associated with a persistent
ATR-CHK1-p53-CDKN1A-dependent DDR, perturbed repli-
some dynamics, and genomic instability, as evidenced by an
increased polyploidy.
USP1 Depletion Causes Aggregation of Chromatin-
Bound FD2, FD2-Dependent Checkpoint Activation,
and Sensitization to Mitomycin C
FD2-Ub is implicated in senescence by transcriptional activation
of pro-senescence transcription factors and p53 homolog
TAp63 in MEFs (Park et al., 2013). We therefore measured
whether USP1 depletion leads to increased TAp63 mRNA levels
in human fibroblasts. Neither our transcriptomic RNA-seq data
(Neyret-Kahn et al., 2013) nor relative mRNA levels indicated
any increase of TAp63 mRNA levels (Figures S5A and S5B).
FD2-Ub undergoes a USP1-dependent recycling process and
transiently localizes to chromatin to form distinct foci in S/G2
phase or in response to DNA damage induced by interstrand
crosslinking agents like mitomycin C (MMC) (Kim et al., 2009).
We speculated that USP1 depletion could cause an aberrant
accumulation of FD2-Ub at chromatin, thus impairing its proper
function and leading to increased polyploidy, replicative stress,
and DDR-mediated senescence arrest. To prove this hypothesis
correct, we first measured the FD2-Ub level and FD2 subnuclear
localization in control and USP1-depleted senescent cells. While
we detected a strong increase in the global FD2-Ub (FD2-L) level
in whole-cell lysates prepared from senescent cells silenced for
USP1 (Figure 4A), this was not the case for mono-ubiquitinated
FI (Figure S5D) and PCNA (Figure S5E), although FI expression
was moderately elevated in senescent cells (Figures S5C and
S5D). Biochemical fractionation showed that FD2 was morecontrol vector (shC) and shUSP1-expressing BJ fibroblasts after senescence
XSN-16E7/shC, or LXSN/shUSP1; (F) LXSN-16E6/shUSP1 or LXSN/shUSP1;
each time point are the mean value of triplicates ± SEM.
arker Ki67 and SABG at day 10 post-selection are shown.
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Figure 3. USP1 Silencing Induces ATM-Independent but ATR-Dependent Senescence Arrest and Replication Stress
(A and B) Proliferation curves of BJ fibroblasts co-expressing pRETROSUPER-shScramble (shC) or pRETROSUPER-shUSP1 together with (A) RETROSUPER-
shATM and -shCHK2 or (B) lentiviral shATR/shC or shATR/shUSP1-1 and shATR/shUSP1-2 (shATR/shUSP1-1/2) shUSP1-1 and 1-2 are two independent
shUSP1 retroviral constructs. PDs for each time point are the mean value of triplicates ± SEM.
(C) Percentages of cells incorporating EdU of cell populations from (B) at day 3 after selection are shown.
(D) Immunoblot analysis, using antibodies directed against RAD17, phospho-RAD17 (Rad17pSer645), CHK1, and phospho-CHK1 (CHK1pSer345) in whole-cell
lysates prepared from BJ fibroblasts expressing control vector shC or shUSP1 at day 6 after selection, is shown.
(legend continued on next page)
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tightly associatedwith chromatin-bound fractions P2, P3 (DNase
I-resistant chromatin fraction), and S4 ((NH4)2SO4-extracted
pure chromatin fraction) and nuclear matrix fraction P4 in
USP1-deficient cells when compared to control cells. Consistent
with this, indirect immunofluorescence staining using detergent
pre-extraction before crosslinking (this procedure extracts all
non-chromatin-bound FD2) revealed that FD2 exhibited
numerous, abnormally large FD2 aggregates in USP1-depleted
and oncogenic RAS-induced senescent cells and a strong nu-
clear rim staining when compared to control cells (shC) or
MMC-treated shC-expressing cells (Figure 4B). By contrast,
we only observed amodest increase in FI foci formation intensity
(Figure S5F). Together, these results confirm previous studies re-
porting that mono-ubiquitination of FD2 triggers chromatin and
nuclear matrix targeting (Matsushita et al., 2005; Montes de
Oca et al., 2005; Oestergaard et al., 2007).
If an aberrant localization of FD2-Ub was indeed a gatekeeper
for senescence induced by USP1 depletion, then reduced FD2
levels should mitigate the maintenance of senescence upon
USP1 depletion. Indeed, transient and stable FD2 silencing of
fully senescence-arrested USP1-depleted cells caused a
3-fold increase in EdU-incorporating cells (i.e., cells re-starting
DNA replication) when compared to control cells, which was
comparable to cells silenced for CDKN1A but 2-fold less when
compared to cells treated with small interfering RNA (siRNA)
against p53. Interestingly, we also observed a small but signifi-
cant 1.6-fold increase in EdU incorporation in FI-depleted
senescent cells, suggesting that unmodified FI plays a role in
replisome dynamics, as shown previously (Figure 4C; Fig-
ure S5G) (Chen et al., 2015). Stable shUSP1/shp53-expressing
cells also expanded, whereas shUSP1/shFD2-expressing cells
did not, despite re-starting DNA replication, as evidenced by
an3-fold increase in EdU incorporation (Figure 4D; Figure S5H).
This is in line with previous data showing that FD2 is necessary
for cell proliferation (Lossaint et al., 2013). Altogether these re-
sults demonstrate that FD2/FD2-Ub, FI, CDKN1A, and p53 are
crucial factors for maintenance of the senescence arrest in
USP1-depleted cells, and they emphasize the critical role of
FD2-FD2Ub in replisome function and proliferative homeostasis
(Lossaint et al., 2013; Panneerselvam et al., 2014).
Given the aberrant aggregation of FD2-Ub in USP1-silenced
cells, we next asked whether such cells, similar to FA dysfunc-
tional cells, would be more sensitive to DNA crosslinking agent
MMC. We thus treated E6/shC control and E6/shUSP1 senes-
cence-bypassing cells with increasing amounts of MMC for
cell survival determination. Indeed, we found that, at a dose
range of 10–20 ng/ml MMC, shUSP1-expressing cells exhibited(E) Neutral (pH 8.0) and alkaline (pH 12.8) comet assays were performed in BJ fib
double-stranded (ds) DNA damage, and alkaline condition detects single-strand
represent the mean ± SD of 20 comets.
(F) Indirect immunofluorescence staining using antibodies directed against 53BP1
marked by arrows. Size marker, 10 mm. Inset shows magnification of 53BP1 foc
(G) Quantification of 53BP1 nuclear bodies in BJ fibroblasts expressing control v
(H and I) Single-molecule analysis of DNA replication using molecular DNA combi
shUSP1 constructs at day 4 after transduction when cells begin to enter senesc
whiskers graph for mean fork velocity kilobase per minute ± SEM was plotted
megabase ± SEM in scramble versus USP1-shRNA samples is shown. Box-and
(****p < 0.02, n = 100).an 2- to 3-fold higher drug-related cytotoxicity over control
cells (Figure 4E). This increased sensitivity to MMC also corre-
lated with aberrant FD2 foci formation in these cells. While un-
treated USP1-silenced cells had a higher basal level and broader
size distribution of FD2 foci than control cells, in MMC-treated
control cells, the number of FD2 foci increased significantly,
albeit with a very narrow FD2 foci size distribution, while the
number of FD2 foci in MMC-treated USP1-silenced cells
decreased and their foci size distribution shifted to much larger
foci sizes (Figure 4F; Figure S5I).
Altogether, these results show that USP1 depletion causes
aberrant FD2/FD2-Ub aggregation, which, in WT cells, helps to
maintain FD2/FI/p53/CDKN1A-dependent senescence arrest
and, in senescence-compromised cells, sensitizes to DNA
crosslinking agent-induced cell death.
DISCUSSION
Here, we provide strong evidence that perturbation of the DUB
USP1 plays a previously unrecognized role for the onset and
maintenance of OIS through the activation of a chronic DDR
that depends on functional FD2, FI, ATR, CHK1, p53, and
CDKN1A signaling.
Consistently, we show that, in primary human cells,
decreased USP1 expression contributes to senescence onset
and, conversely, that complementing cells undergoing OIS
with WT USP1 delays it. USP1 repression is a very early event
in OIS, preceding, for example, upregulation of pro-senescence
factor CDKN1A, suggesting that USP1 is instrumental for the
timely execution of senescence. USP1 depletion indeed
partially phenocopies a robust OIS response by doing the
following: (1) a pronounced G2/M cell-cycle block and an in-
crease in ploidy; (2) an increased number of cells staining pos-
itive for large 53BP1 and gH2Ax DNA damage foci (Di Micco
et al., 2006); (3) the activation/phosphorylation of ATR, CHK1,
and p53 and induction of its transcriptional target CDKN1A;
(4) an enhanced FD2 aggregation; (5) an increased expression
of SASP factors (Rodier et al., 2009); and, finally, (6) moderate
replication stress as evidenced by reduced replication fork
speed and an increased activation of dormant origins. Moder-
ate replication stress activates ATR, leading to the phosphory-
lation of its downstream targets RAD17 (Koundrioukoff et al.,
2013) and to the induction of genomic instability and cell-cycle
perturbation in homologous recombination-deficient cells (Wil-
helm et al., 2014). The unusually large 53BP1 damage foci we
observed in USP1-depleted cells resembled OPT domains or
53BP1 nuclear bodies. The former accumulate at fragile sitesroblasts expressing control vector shC or shUSP1. Neutral condition detects
ed (ss) DNA damage. H2O2 was used as a positive control. Scatter dot plots
and gH2AX in BJ fibroblasts expressing control vector shC or shUSP1. Foci are
i for clarity.
ector shC or shUSP1 is shown.
ng are depicted for BJ fibroblasts stably expressing lentiviral shControl (shC) or
ence. For experimental details please see Figures S4A and S4B. (H) Box-and-
(****p < 0.02, n = 100). (I) Number of replication origin initiation events per
-whiskers graph of replication events per megabase DNA fibers was plotted
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Figure 4. USP1 Depletion Causes Aberrant Accumulation and Aggregation of FD2/FD2-Ub in the Nucleus, FD2-Dependent Checkpoint
Activation, and Sensitization to Crosslinking Reagents
(A) Immunoblot analysis of whole-cell lysate (WCL) and fractionated nuclei of shC and shUSP1-expressing BJ fibroblasts. FD2-S indicates unmodified FD2 and
FD2-L indicates mono-ubiquitinated FD2. Nuclei were fractionated into the following: S2, nucleosol and soluble chromatin; P2, chromatin-bound/nuclear matrix
fraction; S3, DNase I-sensitive chromatin fraction; P3, DNase I-resistant chromatin fraction; S4, (NH4)2SO4-extracted highly purified chromatin fraction; and P4,
insoluble nuclear matrix fraction.
(B) Indirect immunofluorescence microscopy, using antibody directed against FD2 and DAPI DNA counterstain for indicated cell populations, is shown.
Scale bar, 10 mm.
(legend continued on next page)
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after exposure to replicative stress and become apparent in G1
phase of the next cell cycle (Harrigan et al., 2011; Lukas et al.,
2011). It is tempting to speculate that USP1 deficiency prefer-
ably produces replication stress and genomic instability at frag-
ile sites. Together, these data suggest that 53BP1 and gH2AX
co-localizing DNA damage foci and the elevated number of
polyploid cells may derive from a singular breakage event dur-
ing their passage to M phase. This is supported by the recent
finding implicating a dysfunctional FA pathway in cytokinesis
failure (Vinciguerra et al., 2010). Remarkably, USP1 depletion
in senescence-bypassing cells equally induces replication
stress, perturbed S/G2 transition, and polyploidy, implying
that USP1 deficiency creates a milieu conducive for genomic
instability and an increased risk for transformation when the
senescence response is compromised.
Mono-ubiquitinated FANCD2 (FD2-Ub) is a primary substrate
of USP1 (Nijman et al., 2005). Cells derived from USP1 KO mice
accumulate FD2-Ub at chromatin, assemble FD2DNA repair foci
improperly, and are hyper-sensitive to MMC (Kim et al., 2009),
which is congruent with our findings in human cells. These
results suggest that senescence-compromised cancer cells
expressing low levels of USP1 or treatment of cancer cells ex-
pressing high levels of USP1 with USP1 inhibitors may be
more susceptible to MMC-mediated cell death, an idea that is
corroborated by our findings in USP1-depleted senescence-by-
passing HPVE6 cells that indeed undergo increased cell death
after MMC treatment.
USP1 KO mice have a reduced rate of epidermal carcinogen-
esis, and acute depletion of USP1 in MEFs induced FD2-Ub-
dependent senescence. In this context, FD2-Ub controls
expression of pro-senescence factor TAp63, and, consistently,
in TAp63-dysfunctional cells, USP1 depletion failed to induce
senescence (Park et al., 2013). In our human fibroblast senes-
cence model, TAp63 upregulation was absent, indicating that
acute loss of USP1 function likely produces qualitatively different
senescence responses depending on cell type and species. In
this respect, it would be interesting to see whether USP1 deple-
tion in MEFs induces a DDR and replication stress.
A recent study reported that FD2 depletion in human cells in-
duces replication stress and cellular senescence (Lossaint et al.,
2013). We also observed moderate replication stress in USP1-
depleted cells undergoing senescence, as exemplified by
elevated origin firing and decreased fork velocity, yet, in the
presence of pathologically high FD2-Ub quantities. Thus, senes-
cence arrest associated with replication stress can be a result
both of reduced FD2 in S phase or abnormally high FD2-Ub
S/G2 phase levels during normal replication. This last point is un-
derscored by our finding that fully senescent cells co-depleted
for USP1 and FD2 re-enter the cell cycle and actively replicate,(C) USP1-depleted senescent BJ fibroblasts were transfected with siC, siFD2,
measured thereafter over a period of 24 hr. Data are mean of three independent
(D) Proliferation curve (left panel) and EdU incorporation (right panel) of USP1-d
constructs. 48 hr after transduction, EdU incorporation was measured over a pe
(E) Survival curve of HPV16E6/shC and HPV16E6/shUSP1-expressing BJ fibrobla
(F and G) Quantifications of FD2 foci number per nucleus (F) and FD2 foci size
with 10 ng/ml MMC for 5 days using indirect immunofluorescence staining with
triplicates ± SEM.a least for one round, before they re-senesce due to FD2 defi-
ciency (Lossaint et al., 2013).
Our senescence escape experiment revealed the involvement
of another USP1 target and FA-complex component: FI.
Although we did not detect increased mono-ubiquitination of FI
in USP1-depleted senescent cells, FI depletion led, similar to
FD2 depletion, to a moderate increase in cells exiting the senes-
cence arrest. Thus, FI affects re-initiation of replication in our
senescence context; however, this effect seems to be indepen-
dent of its mono-ubiquitination level. This is consistent with
recent reports suggesting that FI has mono-ubiquitination-
dependent as well as -independent regulatory roles in FA
function at sites of DNA damage (Chen et al., 2015; Castella
et al., 2015; Chaudhury et al., 2013). Thus, the role of FI in repli-
cation is complex and needs further investigation.
We also did not observe increased mono-ubiquitination of
another principal target of USP1: PCNA. PCNAmono-ubiquitina-
tion predominantly occurs in cells exposed to DNA-damaging
agents generating chemical alterations in DNA. However, agents
that generate double-strand breaks do not induce PCNA mono-
ubiquitination, which is also independent of ATR-mediated
checkpoint activation (Niimi et al., 2008). PCNA mono-ubiquiti-
nation also is dependent on RAD18 to recognize single-stranded
DNA (ssDNA) and is mediated by RPA. Importantly, we detected
neither prominent RPA foci, which are indicative of lesion-
induced ssDNA, nor any other overt DNA damage, as evidenced
by comet assay, in USP1-depleted cells. In addition, RAD18 is
downregulated in OIS cells according to our transcriptome
data. Together, these data are consistent with the notion that
senescence mediated by USP1 depletion does not produce
DNA lesions that cause PCNA mono-ubiquitination.
Finally, we addressed the question of whether or not USP1-
mediated senescence is dependent on ID HLH transcription
factors. USP1 promotes ID protein stability. ID proteins are over-
expressed in various human cancers and are potent inhibitors of
differentiation and senescence by downregulating CDKN1A and
inhibiting Rb functions (Zebedee and Hara, 2001; Williams et al.,
2011). Based on these data, we reasoned that ID1 and ID2 over-
expression in USP1-depleted cells may lead to senescence
delay or bypass. This was, however, not the case and cells
entered senescence with the same kinetics as controls. Impor-
tantly, upregulation of CDKN1A expression was not altered.
Together, these data provide strong evidence that the main
effect of USP1 loss in our cellular context is on mono-ubiquitina-
tion of FD2 and that mono-ubiquitination of other known targets,
including FI, PCNA, and ID proteins, is unaltered.
In conclusion, we unravel an unexpected function of USP1 in
regulating genomic stability and proliferative homeostasis
by limiting the production of dysfunctional aggregation ofsip53, and siCDKN1A SMARTPOOLs for 2 days, and EdU incorporation was
experiments ± SEM.
epleted senescent BJ fibroblasts transduced with indicated lentiviral shRNA
riod of 24 hr. Data are the mean value of triplicates ± SEM.
sts treated for 5 days with increasing amounts of mitomycin C (MMC) is shown.
per nuclear surface area (G) in cell populations from (E), untreated or treated
an antibody directed against FD2, are shown. Data are the mean values of
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chromatin-bound mono-ubiquitinated FD2 protein, polyploidy,
replication stress, and chronic DNA damage signaling. More
importantly, we identify USP1 as part of a replication stress
response mechanism in addition to known FA proteins FD2
and FI. Our data corroborate the idea that a prolonged physical
interaction of DNA repair factors with chromatin is an important
step in the chronic activation of the DDR-signaling cascade dur-
ing OIS, as previously shown for ATR and other DDR factors
ectopically targeted to chromatin (Toledo et al., 2008; Soutoglou
and Misteli, 2008).
EXPERIMENTAL PROCEDURES
Senescence Analysis
Senescence was assessed using several assays as previously published
(Benhamed et al., 2012). Briefly, proliferative capacity was determined by
growth curves, indirect immunofluorescence using anti-Ki67 antibody staining
(Boehringer Mannheim), or EdU Click-iT chemistry (Invitrogen) as per the man-
ufacturer’s instructions. Cells were also co-stained for SABG activity.
Transfection and siRNA Treatment
Cells were transfected with indicated vector constructs using X-tremeGENE
HP DNA transfection Reagent (Roche) or siIMPORTER (Millipore). For siRNA
transfection experiments, cells were transfected at 100 nM. All siRNA
duplexes were Smart Pools (Dharmacon) and have been validated previously.
Respective scrambled sequences were used as negative controls. Cells were
harvested at the indicated time points and analyzed.
Comet Assay
The single-cell gel electrophoresis (comet assay) was performed according to
the manufacturer’s protocol (Trevingen). Tail moments (= tail length 3 DNA in
the tail/total DNA) were analyzed using the Tritek Comet Score freeware and
further analyzed in GraphPad Prism 6.
Statistical Analysis
Results are shown as means ± SD or SEM, as indicated. The p values were
calculated by Student’s two-tailed t test, except for DNA-combing data, for
which the Mann-Whitney non-paremetrical test was used as indicated.
The data from the genome-wide expression analysis used in this study may
be viewed under GEO: GSE33710 and GSE42213.
SUPPLEMENTAL INFORMATION
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five figures, and one table and can be found with this article online at http://
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